Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases

Clinical and Experimental Immunology

Volumn 162, Issue 1, 2010, Pages 100-107

  Marzano, A V ^a   Cugno, M ^a   Trevisan, V ^a   Fanoni, D ^a   Venegoni, L ^a   Berti, E ^a   Crosti, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

cytokines; matrix metalloproteinases; neutrophilic dermatoses; pyoderma gangrenosum; Sweet's syndrome

Indexed keywords

CD163 ANTIGEN; CD3 ANTIGEN; CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 17; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADOLESCENT; ADULT; AGED; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MACROPHAGE; MALE; NEUTROPHIL; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYODERMA GANGRENOSUM; SKIN DISEASE; SKIN INJURY; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CYTOKINES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; PYODERMA GANGRENOSUM; RECEPTORS, CELL SURFACE; SWEET SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77956502143     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04201.x     Document Type: Article

References (26)

1. Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 2009 23 : 1008 1017.
2. Marzano AV, Tourlaki A, Alessi E, Caputo R. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab. Clin Exp Dermatol 2008 33 : 156 159.
3. Marzano AV, Trevisan V, Galloni C, Alessi E. Fatal bullous pyoderma gangrenosum in a patient with Klinefelter's syndrome. Acta Derm Venereol 2008 88 : 158 159.
4. Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009 10 : 301 312.
5. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005 53 : 273 283.
6. Marzano A, Trevisan V, Lazzari R, Crosti C. Topical tacrolimus for the treatment of localized, idiopathic newly diagnosed pyoderma gangrenosum. J Dermatol 2010 21 : 140 143.
7. Cohen PR. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007 2 : 34.
8. Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. J Am Acad Dermatol 1983 9 : 751 758.
9. Reguiai Z, Grange F. The role of anti-tumor necrosis factor-alpha therapy in Pyoderma gangrenosum associated with inflammatory bowel disease. Am J Clin Dermatol 2007 8 : 67 77.
10. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991 9 : 617 648.
11. Oka M, Berking C, Nesbit M et al. Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 2000 80 : 595 604.
12. Oka M. Pyoderma gangrenosum and interleukin 8. Br J Dermatol 2007 157 : 1279 1281.
13. Saito S, Yasui K, Hosoda W et al. CD30+ anaplastic large cell lymphoma complicated by pyoderma gangrenosum with increased levels of serum cytokines. Eur J Haematol 2006 77 : 251 254.
14. Jones SC, Evans SW, Lobo AJ, Ceska M, Axon AT, Whicher JT. Serum interleukin-8 in inflammatory bowel disease. J Gastroenterol Hepatol 1993 8 : 508 512.
15. Pene J, Chevalier S, Preisser L et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008 180 : 7423 7430.
16. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009 361 : 888 898.
17. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009 157 : 209 215.
18. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 1999 162 : 494 502.
19. Ruddy MJ, Wong GC, Liu XK et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004 279 : 2559 2567.
20. Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 2008 35 : 515 519.
21. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998 10 : 602 608.
22. Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 2001 151 : 121 148.
23. Gao Q, Meijer MJ, Kubben FJ et al. Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases. Dig Liver Dis 2005 37 : 584 592.
24. Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Resp Cell Mol Biol 1996 14 : 288 295.
25. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005 9 : 777 794.
26. Zittermann SI, Issekutz AC. Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation. J Leukoc Biol 2006 80 : 247 257.